Drug
Laninamivir clinical trials
Also written CS-8958.
- studies test it
- 8
- open now
- 1
- in phase 3
- 1
- first study started
- 2007
Keep track of what changes. Save the laninamivir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
8 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 1
Biota Scientific Management Pty Ltd (6) · Daiichi Sankyo Co., Ltd. (1) · University of Oxford (1)
Often tested with
Tested in the same studies.
CS 8958 (4) · Oseltamivir (1) · Favipiravir (1) · Zanamivir (1) · Baloxavir (1) · Molnupiravir (1) · Peramivir (1)
Studies
Open first, then newest update. How each study uses laninamivir is read from its arms, and is right about nine times in ten.
Testing it · 8
- A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingPhase 2University of OxfordNCT05648448Written as Laninamivir
- Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaTerminatedPhase 1/2Biota Scientific Management Pty LtdNCT02014649Written as 20 mg laninamivir octanoate
- A Multinational Phase III Study of CS-8958 (MARVEL)CompletedPhase 3Daiichi Sankyo Co., Ltd.NCT00803595Written as CS-8958
- CS-8958 Single Inhaled Dose in ElderlyCompletedPhase 1Biota Scientific Management Pty LtdNCT00657111Written as CS-8958 formulated as dry powder
- Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With InfluenzaCompletedPhase 2Biota Scientific Management Pty LtdNCT01793883Written as 40 mg Laninamivir Octanoate
- Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958CompletedPhase 1Biota Scientific Management Pty LtdNCT00995826Written as CS-8958
- Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958CompletedPhase 1Biota Scientific Management Pty LtdNCT00311714Written as CS-8958 formulated as dry powder
- Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic AsthmaCompletedPhase 1Biota Scientific Management Pty LtdNCT02022761Written as Laninamivir octanoate
Codes
What other systems call laninamivir · ClinicalTrials.gg INT005567
- MeSH (NLM) C546918laninamivirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) B408IW3GL5LANINAMIVIRConfirmed FDA, NLM, Wikidata
- Wikidata Q6487096laninamivirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C174629LaninamivirOne source FDA
- DrugBank DB12791One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C546918 | laninamivir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | B408IW3GL5 | LANINAMIVIR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6487096 | laninamivir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C174629 | Laninamivir | One source FDA |
| DrugBank | DB12791 | — | One source Wikidata |
Also registered as laninamivir octanoate (UNII E026V904RL), laninamivir octanoate monohydrate (UNII MCG28BI87W) and laninamivir trifluoroacetate (UNII J516WFO3MJ).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.